優博訊(300531.SZ)與農業銀行正式簽訂智能手持POS設備入圍項目採購協議
格隆匯11月21日丨優博訊(300531.SZ)公佈,公司於2019年10月26日披露,確定公司在中國農業銀行股份有限公司傳統有線及智能手持POS設備入圍項目第二包智能手持POS設備招標中中標。
近日,公司與中國農業銀行股份有限公司就上述中標項目正式簽訂了《中國農業銀行智能手持POS設備入圍項目採購協議》。
該合同的簽訂使該項目得到有效落實,若未來能夠順利實施,將對公司的經營業績產生積極影響,但由於該協議為框架協議,公司目前無法預計該協議的簽署和履行對本年度以及未來各會計年度經營業績影響的具體金額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.